The critical role of mRNA destabilizing protein heterogeneous nuclear ribonucleoprotein D in 3′ untranslated region-mediated decay of low-density lipoprotein receptor mRNA in liver tissue

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 1, 2014, Pages 8-16

  Singh, Amar Bahadur ^a,b   Li, Hai ^a,b   Kan, Chin Fung Kelvin ^a   Dong, Bin ^a,b   Nicolls, Mark R ^a,b   Liu, Jingwen ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3 untranslated regions; AU rich elements; Berberine; Hypercholesterolemia; Receptors, LDL; RNA stability

Indexed keywords

ALBUMIN; BERBERINE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; LOW DENSITY LIPOPROTEIN RECEPTOR; LUCIFERASE; LUCIFERIN; MESSENGER RNA; PROTEIN P37;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AU RICH ELEMENT; BIOLUMINESCENCE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE OVEREXPRESSION; GENE SILENCING; HALF LIFE TIME; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; LIVER; LIVER CELL; MOUSE; NONHUMAN; NONSENSE MEDIATED MRNA DECAY; OOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; RNA DEGRADATION; RNA STABILITY; TRANSGENIC MOUSE;

EID: 84891837045     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.301131     Document Type: Article

References (39)

1. Nakajima K, Nakajima Y, Takeichi S, Fujita MQ. Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases. Atherosclerosis. 2008;198:237-246
2. Homma Y. Predictors of atherosclerosis. J Atheroscler Thromb. 2004;11:265-270
3. Spady DK. Hepatic clearance of plasma low density lipoproteins. Semin Liver Dis. 1992;12:373-385
4. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34-47
5. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990;343:425-430
6. Brown MS, Goldstein JL. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89:331-340
7. Brown MS, Goldstein JL. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A. 1999;96:11041-11048
8. Seidah NG, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin SB, Stifani S, Basak A, Prat A, Chretien M. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation. Proc Natl Acad Sci U S A. 2003;100:928-933
9. Abifadel M, Varret M, Rabès JP, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet. 2003;34:154-156
10. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A. 2003;100:12027-12032
11. Maxwell KN, Soccio RE, Duncan EM, Sehayek E, Breslow JL. Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. J Lipid Res. 2003;44:2109-2119
12. Wilson GM, Vasa MZ, Deeley RG. Stabilization and cytoskeletalassociation of LDL receptor mRNA are mediated by distinct domains in its 3' untranslated region. J Lipid Res. 1998;39:1025-1032
13. Wilson GM, Roberts EA, Deeley RG. Modulation of LDL receptor mRNA stability by phorbol esters in human liver cell culture models. J Lipid Res. 1997;38:437-446
14. Goto D, Okimoto T, Ono M, Shimotsu H, Abe K, Tsujita Y, Kuwano M. Upregulation of low density lipoprotein receptor by gemfibrozil, a hypolipidemic agent, in human hepatoma cells through stabilization of mRNA transcripts. Arterioscler Thromb Vasc Biol. 1997;17:2707-2712
15. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Li Z, Liu J, Jiang J-D. Berberine is a promising novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004;10:1344-1352
16. Yamamoto T, Davis CG, Brown MS, Schneider WJ, Casey ML, Goldstein JL, Russell DW. The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA. Cell. 1984;39:27-38
17. Zhang T, Kruys V, Huez G, Gueydan C. AU-rich element-mediated translational control: Complexity and multiple activities of trans-Activating factors. Biochem Soc Trans. 2002;30(pt 6):952-958
18. Meyer S, Temme C, Wahle E. Messenger RNA turnover in eukaryotes: Pathways and enzymes. Crit Rev Biochem Mol Biol. 2004;39:197-216
19. Briata P, Chen CY, Giovarelli M, Pasero M, Trabucchi M, Ramos A, Gherzi R. KSRP, many functions for a single protein. Front Biosci (Landmark Ed). 2011;16:1787-1796
20. Knouff C, Malloy S, Wilder J, Altenburg MK, Maeda N. Doubling expression of the low density lipoprotein receptor by truncation of the 3'-untranslated region sequence ameliorates type iii hyperlipoproteinemia in mice expressing the human apoe2 isoform. J Biol Chem. 2001;276:3856-3862
21. Nakahara M, Fujii H, Maloney PR, Shimizu M, Sato R. Bile acids enhance low density lipoprotein receptor gene expression via a MAPK cascademediated stabilization of mRNA. J Biol Chem. 2002;277:37229-37234
22. Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, Huo L, Wang M, Hong J, Wu P, Ren G, Ning G. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008;93:2559-2565
23. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57:712-717
24. Wei W, Zhao H, Wang A, Sui M, Liang K, Deng H, Ma Y, Zhang Y, Zhang H, Guan Y. A clinical study on the short-Term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J Endocrinol. 2012;166:99-105
25. Li H, Chen W, Zhou Y, Abidi P, Sharpe O, Robinson WH, Liu J. Identification of mRNA-binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements. J Lipid Res. 2009;50:820-831
26. Pinkert CA, Ornitz DM, Brinster RL, Palmiter RD. An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Dev. 1987;1:268-276
27. Izban MG, Papaconstantinou J. Cell-specific expression of mouse albumin promoter. Evidence for cell-specific DNA elements within the proximal promoter region and cis-Acting DNA elements upstream of -160. J Biol Chem. 1989;264:9171-9179
28. Wu Y, Wang YY, Nakamoto Y, Li YY, Baba T, Kaneko S, Fujii C, Mukaida N. Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver. Oncogene. 2010;29:2228-2237
29. Raineri I, Wegmueller D, Gross B, Certa U, Moroni C. Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Res. 2004;32:1279-1288
30. Loflin P, Chen CY, Shyu AB. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev. 1999;13:1884-1897
31. Barker A, Epis MR, Porter CJ, Hopkins BR, Wilce MC, Wilce JA, Giles KM, Leedman PJ. Sequence requirements for RNA binding by HuR and AUF1. J Biochem. 2012;151:423-437
32. Mazan-Mamczarz K, Kuwano Y, Zhan M, White EJ, Martindale JL, Lal A, Gorospe M. Identification of a signature motif in target mRNAs of RNAbinding protein AUF1. Nucleic Acids Res. 2009;37:204-214
33. Pont AR, Sadri N, Hsiao SJ, Smith S, Schneider RJ. mRNA decay factor AUF1 maintains normal aging, telomere maintenance, and suppression of senescence by activation of telomerase transcription. Mol Cell. 2012;47:5-15
34. Flores-Muñoz M, Godinho BM, Almalik A, Nicklin SA. Adenoviral delivery of angiotensin-(1-7) or angiotensin-(1-9) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptor. PLoS One. 2012;7:e45564
35. Monet M, Francoeur N, Boulay G. Involvement of phosphoinositide 3-kinase and PTEN protein in mechanism of activation of TRPC6 protein in vascular smooth muscle cells. J Biol Chem. 2012;287:17672-17681
36. King SR, Matassa AA, White EK, Walsh LP, Jo Y, Rao RM, Stocco DM, Reyland ME. Oxysterols regulate expression of the steroidogenic acute regulatory protein. J Mol Endocrinol. 2004;32:507-517
37. Derosa G, D'Angelo A, Bonaventura A, Bianchi L, Romano D, Maffioli P. Effects of berberine on lipid profile in subjects with low cardiovascular risk. Expert Opin Biol Ther. 2013;13:475-482
38. Pisciotta L, Bellocchio A, Bertolini S. Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment. Lipids Health Dis. 2012;11:123
39. Zhai B, Yang H, Mancini A, He Q, Antoniou J, Di Battista JA. Leukotriene B(4) BLT receptor signaling regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of Ras/Raf/ERK/ p42 AUF1 pathway. J Biol Chem. 2010;285:23568-23580